Clinical Trial Update: Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating long-term safety and efficacy of elagolix for moderate to severe endometriosis-associated pain completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Elagolix (elagolix)

Snippet

Sponsor: AbbVie | Conditions: Endometriosis | Phase 3 | Status: COMPLETED | Results posted: 2018-09-07